Takao Orii

Establishment of the MID‐NET^® medical information database network as a reliable and valuable database for drug safety assessments in Japan

Mitsune Yamaguchi, Satomi Inomata, Sayoko Harada et al. · Pharmacoepidemiology and Drug Safety · 2019 · 90 citations · Full text

Computing, Biomedical Informatics, Health Informatics +16

Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria

Hirokazu Nakayama, Kensuke Usuki, Hirotoshi Echizen et al. · Biological and Pharmaceutical Bulletin · 2016 · 44 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information

Chia‐Hsien Chang, Makiko Kusama, Shunsuke Ono et al. · BMJ Open · 2013 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The utilization and challenges of Japan's MID‐NET^® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies

Kaori Yamada, Maori Itoh, Yoshiaki Fujimura et al. · Pharmacoepidemiology and Drug Safety · 2019 · 40 citations

Pharmacy, Clinical Pharmacy, Pharmacology +17

Urinary Lipocalin-Type Prostaglandin D Synthase: A Potential Marker for Early Gentamicin-Induced Renal Damage?

Hirokazu Nakayama, Hirotoshi Echizen, Tomoko Gomi et al. · Therapeutic Drug Monitoring · 2009 · 18 citations

Medicine, Nephrology, Pharmacotherapy +16